Technology News and Headlines

IQVIA Signs Agreement to Acquire Drug Discovery Assets From Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

IQVIA Holdings announced an agreement to acquire five drug discovery service sites from Charles River Laboratories, adding in‑vitro capabilities, New Approach Methodologies and a small‑molecule AI platform. The assets, built on more than 20 years of data, have helped launch over 100 molecules into clinical trials, including several approved drugs. Integration will create an end‑to‑end discovery platform covering target identification through early safety, expanding IQVIA’s reach into oncology, neurology, immunology, metabolism and rare diseases. The transaction is slated to close in the second quarter.